Cargando…
Riok1, A Novel Potential Target in MSI-High p53 Mutant Colorectal Cancer Cells
The vulnerabilities of cancer cells constitute a promising strategy for drug therapeutics. This paper integrates proteomics, bioinformatics, and cell genotype together with in vitro cell proliferation assays to identify key biological processes and potential novel kinases that could account, at leas...
Autores principales: | Shechter, Sharon, Ya’ar Bar, Sapir, Khattib, Hamdan, Gage, Matthew J., Avni, Dorit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254355/ https://www.ncbi.nlm.nih.gov/pubmed/37298928 http://dx.doi.org/10.3390/molecules28114452 |
Ejemplares similares
-
The therapeutic potential of sphingolipids for cardiovascular diseases
por: Ya'ar Bar, Sapir, et al.
Publicado: (2023) -
Microalgae—Sustainable Source for Alternative Proteins and Functional Ingredients Promoting Gut and Liver Health
por: Eilam, Yahav, et al.
Publicado: (2023) -
The RioK1 network determines p53 activity at multiple levels
por: Damizia, Michela, et al.
Publicado: (2023) -
First Evidence of Function for Schistosoma japonicum
riok-1 and RIOK-1
por: Mughal, Mudassar N., et al.
Publicado: (2021) -
Regulation of Cholesterol Metabolism by Phytochemicals Derived from Algae and Edible Mushrooms in Non-Alcoholic Fatty Liver Disease
por: Eilam, Yahav, et al.
Publicado: (2022)